Article Figures & Data
Figures
- FIGURE 1.
Maximum-intensity projection (left) and transaxial (right) slices from whole-body 68Ga-DOTATATE PET/CT (A) and 18F-FDG PET/CT (B) studies demonstrating nearly complete resolution of two lesions in segment VIII and reduced tracer avidity for lesions in segments IVA, VI, and V.
Tables
- TABLE 1
Kidney, Blood, and Liver Parameters at Baseline and 3 Months After First Cycle of PRRT
Kidney Blood Liver Time Urea (mg/dL) Creatinine (mg/dL) Hb (gm%) TLC (/mm3) Platelets (/mm3) SGOT (U/L) SGPT (U/L) ALP (U/L) Bili (mg/dL) Baseline 12.16 0.9 14.6 8,500 261,000 18 10 76 0.6 After 1 cycle 14.2 0.5 13.1 7,000 2,300,000 16 10 74 0.54 Reference value 13−45 0.5–1.5 13−15 4,000–11,000 150,000–450,000 15–37 30–65 50–136 0.3–1.2 Hb = hemoglobin; TLC = total leukocyte count; SGOT = serum glutamic oxaloacetic transaminase; SGPT = serum glutamic pyruvic transaminase; ALP = alkaline phosphatase; Bili = total bilirubin.
- TABLE 2
Kidney Parameters and Serum Chromogranin A at Baseline and 3 Months After First Cycle of PRRT
Time GFR (mL/min) ERPF (mL/min) Serum chromogranin A (ng/mL) Baseline 111.03 544.46 84.29 After 1 cycle 105.63 576.3 81.03 Reference value 80−120 450–600 <98 GFR = glomerular filtration rate; ERPF = effective renal plasma flow.
